# Solitary Cannabis Use in Teens: What a Norwegian National Study Found

> **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637)
> **Publisher:** CED Clinic (https://cedclinic.com)
> **Canonical URL:** https://cedclinic.com/solitary-cannabis-use-teens-norway/
> **Published:** 2026-09-09T09:44:32-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:45:07-04:00
> **Clinical Summary:** solitary cannabis use in teens was associated with more reported harms in a national Norwegian study, but cross-sectional evidence does not prove causation.

---

CED Clinical Relevance #71 High Clinical Relevance A national cross-sectional study identifies solitary cannabis use as a clinically useful context marker among high school students, while requiring careful noncausal interpretation. Search-demand and engagement components are editorially inferred because current GSC data were unavailable.

Clinical Insight | CED Clinic
Among 973 Norwegian high school students who reported past-year cannabis use, 24.3% also reported using cannabis alone. Compared with students reporting social use only, those who also used alone reported more negative consequences across several domains, even after the reported regression models accounted for cannabis-use frequency and other risk factors. Because the surveys were cross-sectional and self-reported, the study cannot establish that solitary use caused those consequences. Clinically, the setting of use may still be a useful, nonjudgmental screening question alongside frequency, product, dose, reasons for use, and functional impact.

Adolescent HealthCannabis UseMental HealthSchool FunctionScreening

AudienceParents, adolescents, clinicians, school health professionals, and cannabis-science readers interested in youth cannabis-use patterns and risk assessment
Primary Topicsolitary cannabis use among high school students and its association with negative consequences
Source[Read the full source](https://pubmed.ncbi.nlm.nih.gov/42551120/)

A national Norwegian study found that about one in four high school students who had used cannabis in the past year also reported using alone. Solitary use was associated with a greater number and variety of negative consequences, including mental-health, relationship, school, and law-enforcement problems. The cross-sectional design identifies a screening signal, not proof that using alone caused those outcomes.

What This Study Teaches Us
Cannabis-use setting may add information beyond frequency alone. In two nationally representative cross-sectional surveys, students who reported both social and solitary cannabis use described more negative consequences than students who reported social use only.

Why This Matters
Questions about frequency can miss context. Asking whether cannabis use occurs alone, socially, before school, during distress, or in response to sleep or mood symptoms may help clinicians and families understand function, risk, and the kind of support a young person may need.

Study SnapshotStudy TypeNationally representative cross-sectional survey analysisPopulationNorwegian high school students reporting past-year cannabis useSurvey Years2021 and 2025Participants973 students; 62.2% maleExposure GroupStudents reporting social cannabis use plus solitary useComparison GroupStudents reporting social cannabis use without solitary useSolitary Use Prevalence24.3% of the analytical sampleNegative ConsequencesMean 5.41 versus 2.89 reported consequencesMental Health ProblemsAdjusted odds ratio 1.7; 95% CI 1.18 to 2.32School ProblemsAdjusted odds ratio 1.8; 95% CI 1.31 to 2.49Relationship ProblemsAdjusted odds ratio 2.1; 95% CI 1.32 to 3.42Law-Enforcement ProblemsAdjusted odds ratio 2.2; 95% CI 1.51 to 3.29Published OnlineJuly 31, 2026PMID42551120DOI10.1016/j.addbeh.2026.108820

Clinical Bottom Line
Solitary cannabis use was common enough to matter and was associated with more reported harms, but the study does not show that solitary use caused those harms or that the same estimates apply outside Norwegian high schools.

Use Setting Added Information Beyond Frequency

Almost all students in the analytical sample reported social cannabis use, while 24.3% also reported using alone. The solitary-use group reported an average of 5.41 negative consequences compared with 2.89 in the social-use-only group.

The abstract states that several associations remained after regression models accounted for cannabis-use frequency and other risk factors. That makes use setting worth asking about, while still leaving open the possibility of residual confounding and reverse direction.

The Associations Spanned Several Parts of Life

Students reporting solitary use had greater adjusted odds of consequences in seven of ten assessed harm domains. The abstract specifically reports mental-health, apathy, relationship, school, and law-enforcement problems.

These are associations within self-reported survey data. They should guide a broader conversation about distress and function, not serve as a diagnosis or a prediction about any individual student.

Cross-Sectional Evidence Cannot Establish Direction

The surveys measured cannabis-use setting, individual characteristics, and reported consequences at the same general time. The design therefore cannot determine whether solitary use preceded the problems, followed them, or reflected other unmeasured factors.

A young person may use alone because of distress, may experience problems alongside more intensive cannabis involvement, or may have other vulnerabilities affecting both patterns. The abstract does not resolve those pathways.

Screening Should Be Curious, Specific, and Nonjudgmental

A useful clinical conversation can ask where, when, with whom, and why cannabis is used, along with frequency, product, route, dose, perceived benefits, unwanted effects, and impact on school, relationships, sleep, mood, and safety.

The goal is not to label solitary use as proof of disorder. It is to notice when the context of use may signal coping, concealment, escalating involvement, or functional difficulty that deserves closer assessment.

How Strong Is This Evidence?
The study used two nationally representative surveys and an analytical sample of 973 past-year cannabis-using high school students. It compared use settings and reported adjusted associations across multiple harm domains, providing population-level evidence that setting may be clinically informative beyond reported frequency.

Where This Paper Deserves Skepticism
The evidence is cross-sectional and self-reported. The accessible abstract does not establish temporal order, eliminate residual confounding, provide causal estimates, or show how the pattern generalizes to other countries, younger adolescents, students outside school, or adolescents with different cannabis markets and social contexts.

What This Paper Does Not Show
The study does not show that solitary cannabis use causes depression, apathy, school difficulty, relationship problems, or law-enforcement contact. It does not establish a diagnostic cutoff, a treatment effect, a safe pattern of use, or a risk estimate for an individual young person. The abstract does not provide product potency, dose, route, or detailed subgroup findings.

How This Fits With the Broader Clinical Conversation

Adolescent cannabis risk is multidimensional. Frequency matters, but so do age at initiation, product potency, route, dose, reasons for use, concurrent alcohol or nicotine use, driving, school function, sleep, mood, family context, and whether use is becoming difficult to control.

Solitary use may be a marker that prompts better questions rather than a conclusion by itself. A private, nonpunitive conversation can help distinguish experimentation from coping, impairment, or a pattern that warrants structured assessment and support.

Dr. Caplan’s Take

*The practical value of this paper is simple: ask about setting. A frequency count can be identical for two students whose relationships with cannabis are very different. Whether use occurs alone, during distress, before obligations, or in ways that interfere with daily life may reveal clinically important context.*

*I would not treat solitary use as a diagnosis or as proof of causation. I would treat it as an invitation to slow down, ask what the young person is trying to change or escape, assess safety and function, and build support without shame or exaggeration.*

What a Careful Reader Should Take Away
Among Norwegian high school students who used cannabis, solitary use was associated with more reported problems and may be a useful screening signal, not a causal verdict.

Evidence Interpretation Guide

Table of Contents

- [How to Interpret Solitary Cannabis Use Evidence Without Overstating It](#How_to_Interpret_Solitary_Cannabis_Use_Evidence_Without_Overstating_It)[A Four-Step Reading Frame](#A_Four-Step_Reading_Frame)
- [Eight Ways to Read the Solitary-Use Signal](#Eight_Ways_to_Read_the_Solitary-Use_Signal)[One Pattern Is a Signal, Not an Identity](#One_Pattern_Is_a_Signal_Not_an_Identity)
- [Add Setting to the Cannabis History](#Add_Setting_to_the_Cannabis_History)
- [Adjustment Does Not Turn Association Into Causation](#Adjustment_Does_Not_Turn_Association_Into_Causation)
- [Look Beyond Frequency to Immediate Risk](#Look_Beyond_Frequency_to_Immediate_Risk)
- [Connection Works Better Than Interrogation](#Connection_Works_Better_Than_Interrogation)
- [Setting Complements Other Youth Risk Evidence](#Setting_Complements_Other_Youth_Risk_Evidence)
- [Confidentiality and Trust Shape What Clinicians Learn](#Confidentiality_and_Trust_Shape_What_Clinicians_Learn)
- [Prospective Studies Must Clarify Direction](#Prospective_Studies_Must_Clarify_Direction)
- [Frequently Asked Questions](#Frequently_Asked_Questions)[Related](#Related)

## How to Interpret Solitary Cannabis Use Evidence Without Overstating It

The study identifies a meaningful association, but its design cannot establish cause and effect.

The most responsible use of the finding is to improve questions, not to assign a label from one behavior.

### A Four-Step Reading Frame

**Evidence type**Recognize this as a cross-sectional survey analysis, not a randomized trial or prospective causal study.

**Population**Keep the estimates anchored to Norwegian high school students who reported past-year cannabis use.

**Outcome meaning**Read the reported consequences as associated self-reported domains rather than proof that solitary use produced them.

**Clinical use**Use the setting question to guide a fuller assessment of function, distress, safety, and support needs.

The Research Question
Among high school students who used cannabis, how common was solitary use and how was it associated with reported negative consequences?

The Family Question
Does using cannabis alone prove that a teenager has cannabis use disorder or that cannabis caused other problems?

The Bottom Line
No single behavior establishes a diagnosis or cause, but the context can help identify when a careful assessment is warranted.

CED Perspective Lens

## Eight Ways to Read the Solitary-Use Signal

Clinical, family, methods, safety, ethics, and research perspectives

Lens OverviewEach viewpoint stays within the peer-reviewed abstract and separates a potentially useful screening marker from causal or diagnostic claims.

#### One Pattern Is a Signal, Not an Identity

A teenager who sometimes uses cannabis alone should not be reduced to a category. In this national Norwegian sample, solitary use was associated with more reported problems, but the survey cannot explain why any one student used alone or whether the pattern came before other difficulties.

The useful next step is an honest conversation about what cannabis is doing in the person’s life. Ask about mood, sleep, stress, school, relationships, safety, product strength, and whether use feels chosen or increasingly hard to control. A respectful discussion is more informative than punishment or assumptions.

Lens takeawayTreat solitary use as a reason for curiosity and support, not a verdict.

#### Add Setting to the Cannabis History

A routine cannabis history often focuses on frequency and route. This study suggests adding a simple contextual question: is use usually social, solitary, or both? The answer can then open a more specific assessment of motives, timing, impairment, secrecy, tolerance, withdrawal, and unsuccessful attempts to cut down.

The association should not be converted into a diagnostic rule. Solitary use is neither necessary nor sufficient for cannabis use disorder. It can, however, help identify a student whose frequency count understates distress or functional impact and who may benefit from validated screening, confidential counseling, or coordinated behavioral-health care.

Lens takeawayUse setting can enrich screening, but diagnosis still requires a complete clinical assessment.

#### Adjustment Does Not Turn Association Into Causation

The reported regression analyses accounted for cannabis-use frequency and multiple other risk factors, and the solitary-use group still had higher odds in several harm domains. Statistical adjustment strengthens the case that setting carries information beyond frequency alone within this dataset.

It does not remove every alternative explanation. Cross-sectional measurement leaves temporal order unresolved, self-report can introduce recall and reporting bias, and unmeasured factors may affect both solitary use and negative consequences. The abstract does not provide enough detail to evaluate every model choice, missing-data decision, or subgroup pattern.

Lens takeawayAdjusted associations are informative, but the study design still limits causal interpretation.

#### Look Beyond Frequency to Immediate Risk

The abstract reports associations with mental-health, school, relationship, apathy, and law-enforcement problems. A safety assessment should also ask about driving, riding with an impaired driver, mixing substances, high-potency products, panic, psychotic symptoms, severe vomiting, injuries, and access to help when something goes wrong.

The paper does not provide a solitary-use threshold that predicts an emergency. The screening value lies in noticing context and responding to the actual risks present. Urgent evaluation is appropriate for suicidal thoughts, severe confusion, chest pain, persistent vomiting, loss of consciousness, or other acute danger.

Lens takeawayContext should trigger specific safety questions, not generalized fear or false reassurance.

#### Connection Works Better Than Interrogation

Parents and caregivers may hear “using alone” and assume the worst. The study supports taking the pattern seriously, but it does not justify certainty about cause, diagnosis, or prognosis. A calm approach is more likely to produce useful information than accusation or surprise testing alone.

Start with observations and concern: changes in attendance, sleep, mood, motivation, friendships, money, or routines. Ask what the young person notices and what support would feel possible. Clear safety limits can coexist with respect, privacy, and a plan to involve a pediatrician, family physician, or behavioral-health professional when problems persist.

Lens takeawayLead with specific observations, listening, and safety planning rather than labels.

#### Setting Complements Other Youth Risk Evidence

Other adolescent cannabis research often examines frequency, potency, age at initiation, cognition, mental health, or academic function. This paper adds a different dimension: whether use occurs alone as well as socially. That context may distinguish students with otherwise similar frequency reports.

The findings should not be blended into a single claim that cannabis explains every associated problem. Different studies use different populations, measures, and designs. The careful synthesis is that use pattern and setting may help identify risk, while prospective evidence is still needed to clarify direction and to test whether screening on setting improves outcomes.

Lens takeawayUse setting adds context to established risk questions without replacing them.

#### Confidentiality and Trust Shape What Clinicians Learn

Adolescents may withhold substance-use information when they expect automatic punishment, disclosure, or judgment. Clinicians should explain confidentiality and its limits clearly, create private time when appropriate, and ask neutral questions that separate safety assessment from moral conclusions.

The study’s associations can support better detection, but they can also be misused to stereotype a young person who uses alone. Ethical care requires proportionate responses based on actual impairment and risk. It also requires attention to the student’s environment, mental health, family stress, and access to treatment rather than placing responsibility on one behavior alone.

Lens takeawayTrustworthy screening protects dignity while making real safety concerns easier to disclose.

#### Prospective Studies Must Clarify Direction

The next research step is to follow adolescents over time. Prospective data could test whether solitary use predicts later changes in mental health, school function, relationships, or cannabis-use severity after accounting for baseline differences and changing exposure patterns.

Future studies should also report product potency, route, dose, motives, social context, concurrent substance use, and clinically meaningful outcomes. Replication outside Norway is important because cannabis markets, school systems, laws, and cultural norms differ. Intervention studies would then need to determine whether asking about setting and responding to identified needs actually improves health or function.

Lens takeawayLongitudinal and intervention research is needed before screening associations become causal claims.

Join the Conversation

Have a question about how this applies to your situation? [Ask Dr. Caplan](https://benjamincaplan.com/ask-dr-caplan)

Want to discuss this topic with other patients and caregivers? [Join the forum discussion](https://cedclinic.com/interact/discussion-forums/)

 
 
 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 

 
 Physician-Led, Whole-Person Care
 A doctor who takes the time to truly understand you.
 Personal care that starts with listening and is guided by experience and ingenuity.

 
 Health, Longevity, Wellness
 One-on-One Cannabis Guidance
 Metabolic Balance
 

 
 [Leave a Message](https://cedclinic.com/contact/)
 [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/)
 [Medical Consulting](https://cedclinic.com/book/)
 [Cannabis Care](https://cedclinic.com/book/)
 
 

 
 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 
 

Share this Evidence Watch

[X](https://twitter.com/intent/tweet?text=Solitary+Cannabis+Use+in+Teens%3A+What+a+Norwegian+National+Study+Found&url=https%3A%2F%2Fcedclinic.com%2Fsolitary-cannabis-use-teens-norway%2F)
[LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2Fsolitary-cannabis-use-teens-norway%2F)
[BlueSky](https://bsky.app/intent/compose?text=Solitary+Cannabis+Use+in+Teens%3A+What+a+Norwegian+National+Study+Found%20https%3A%2F%2Fcedclinic.com%2Fsolitary-cannabis-use-teens-norway%2F)
[Instagram](https://www.instagram.com/drcaplan/)
[Substack](https://doctorapprovedcannabis.substack.com/)
[RSS](https://cedclinic.com/feed/)

Source: [Cannabis use settings matter: National-level prevalence rates, correlates, and consequences of solitary cannabis use among high school students in Norway](https://pubmed.ncbi.nlm.nih.gov/42551120/)

Related Reading at CED ClinicContinue exploring the evidence[Adolescent Cannabis Use and Cognitive Development](https://cedclinic.com/adolescent-cannabis-use-cognitive-development-risk/)

Prospective ABCD context on memory, attention, executive function, and the limits of observational inference.

[Review the developmental evidence](https://cedclinic.com/adolescent-cannabis-use-cognitive-development-risk/)[High-Potency Cannabis Risks: What the Evidence Shows](https://cedclinic.com/high-potency-cannabis-risks/)

A careful discussion of potency, dose, frequency, adolescent vulnerability, and causal uncertainty.

[Read the risk framework](https://cedclinic.com/high-potency-cannabis-risks/)[Social Media Apps and Youth Cannabis Use](https://cedclinic.com/app-specific-social-media-use-adolescent-cannabis/)

A study of app-specific social-media exposure and youth cannabis-use patterns in the ABCD cohort.

[Explore the youth context](https://cedclinic.com/app-specific-social-media-use-adolescent-cannabis/)

## Frequently Asked Questions

What did the Norwegian study examine?

It examined cannabis-use settings among high school students who reported past-year cannabis use, with particular attention to solitary use and its association with reported negative consequences.

How many students were included?

The analytical sample included 973 students from two nationally representative Norwegian high school surveys conducted in 2021 and 2025.

How common was solitary cannabis use?

Among students in the analytical sample, 24.3% reported solitary cannabis use in addition to social use.

What consequences were associated with solitary use?

The abstract reports higher odds across seven of ten harm domains, including mental-health, apathy, relationship, school, and law-enforcement problems.

Did the study prove that solitary use caused those problems?

No. The surveys were cross-sectional, so they cannot establish temporal order or causation.

Did the analysis account for cannabis-use frequency?

Yes. The abstract states that regression models accounted for frequency and multiple other risk factors, but residual confounding can still remain.

Does solitary use diagnose cannabis use disorder?

No. Solitary use is not a diagnostic criterion by itself. Diagnosis requires a complete assessment of symptoms, control, impairment, and consequences.

What should clinicians ask beyond frequency?

They can ask about setting, motives, timing, potency, route, dose, co-use, safety, mood, sleep, school, relationships, and whether use feels difficult to control.

Can these results be generalized to all teenagers?

Not automatically. The sample involved Norwegian high school students who reported past-year cannabis use, and other settings may differ.

Was the full article reviewed for this report?

No. The open-access publisher page could not be retrieved through the available access routes. Study-specific claims are confined to the peer-reviewed PubMed abstract and DOI metadata.

 

### Related

---

### Verification & Medical Governance

- **Lead Clinical Author:** Benjamin Caplan, MD
- **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House).
- **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`).
- **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/).
- **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637).
- **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).
